WebCyclophosphamide Brand Name: Cyclophosphamide Strength: 100 mg HCPCS: J9070 SEER*Rx Category: Chemotherapy Major Drug Class: Alkylating Agent Minor Drug Class: Nitrogen Mustard Oral (Y/N): No FDA Approval Year: 1959 ... WebDRUGS BILLED UNDER MISCELLANEOUS CODES J3490, J3590, J9999 OR C9399 PRIOR AUTHORIZATION COVERAGE INFORMATION Note: Drugs with their own HCPC code may not be billed using a ... CYCLOPHOSPH INJ (cyclophosphamide IV soln) 01/01/22 PA PA DANYELZA (naxitamab-gqgk) 12/04/20 PA PA DEFITELIO (Defibrotide Sodium IV Soln.) …
Correct Coding for Infusions and Injections - NAMAS
WebJ9070: Cyclophosphamide, 100 mg J9098: Injection, cytarabine liposome, 10 mg J9100: Injection, cytarabine, 100 mg J9118: Injection, calaspargase pegol-mknl, 10 units J9119: … WebMany other regimens of intravenous and oral cyclophosphamide have been reported. Dosages must be adjusted in accord with evidence of antitumor activity and/or … genshin ceo
J9070 Cyclophosphamide - CanMED: HCPCS
WebJ0130 Injection abciximab, 10 mg J0131 Injection, acetaminophen, not otherwise specified,10 mg J0132 Injection, acetylcysteine, 100 mg J0133 Injection, acyclovir, 5 mg … Webfor intravenous administration. It is a cardioprotective agent for use in conjunction with doxorubicin. Chemically, dexrazoxane is (S)-4,4'-(1-methyl-1,2-ethanediyl)bis-2,6-piperazinedione. The structural formula is as follows: C. 11 H 16 N 4 O 4 M.W. 268.28 . Dexrazoxane, a potent intracellular chelating agent is a derivative of EDTA. WebDec 22, 2024 · Cyclophosphamide is indicated for the treatment of: malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin's disease, lymphocytic … chris and julie hughes family account